# Filing Detail

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-046074
Filing Date
2024-11-14
Accepted
2024-11-14 17:22:51
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-qa.htm iXBRL | 10-Q/A | 933572
2 |  | ex31-1.htm | EX-31.1 | 18565
3 |  | ex31-2.htm | EX-31.2 | 18808
4 |  | ex32-1.htm | EX-32.1 | 8587
5 |  | ex32-2.htm | EX-32.2 | 8802
| Complete submission text file | 0001493152-24-046074.txt |  | 5819084

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | cdt-20240331.xsd | EX-101.SCH | 61207
7 | XBRL CALCULATION FILE | cdt-20240331_cal.xml | EX-101.CAL | 55805
8 | XBRL DEFINITION FILE | cdt-20240331_def.xml | EX-101.DEF | 232189
9 | XBRL LABEL FILE | cdt-20240331_lab.xml | EX-101.LAB | 401243
10 | XBRL PRESENTATION FILE | cdt-20240331_pre.xml | EX-101.PRE | 303218
72 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-qa_htm.xml | XML | 891077

Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-41245 | Film No.: 241464436
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)